Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ADVB

Advanced Biomed Inc

Mar 14 • 02:28PM ET

3.61

Dollar change +0.08
Percentage change 2.27	%

Healthcare • Diagnostics & Research • Taiwan • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.00	Insider Own	84.83%	Shs Outstand	21.64M	Perf Week	-1.10%
Market Cap	78.12M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	3.28M	Perf Month	-
Income	-0.10M	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Book/sh	0.00	P/B	2256.25	EPS next Y	-	ROA	-	Short Interest	-	Perf Year	-
Cash/sh	0.00	P/C	976.50	EPS next 5Y	-	ROE	-	52W Range	3.06 - 4.10	Perf YTD	-1.10%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-273.54%	52W High	-11.95%	Beta	-
Dividend TTM	-	Quick Ratio	0.95	Sales past 5Y	0.00%	Gross Margin	-	52W Low	17.97%	ATR (14)	0.52
Dividend Ex-Date	-	Current Ratio	0.95	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	-	Volatility	17.11% -
Employees	40	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	50.00%	Payout	-	Rel Volume	0.07	Prev Close	3.53
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	292.32K	Price	3.61
SMA20	-0.88%	SMA50	-0.88%	SMA200	-0.88%	Trades		Volume	15,798	Change	2.27%

Mar-07-25 12:29PM	Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering (GlobeNewswire)
Mar-06-25 09:02AM	Advanced Biomed Inc. Announces Pricing of Initial Public Offering (GlobeNewswire)

Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. It engages in the research & development of microfluidic biochip technologies and provides tumor diagnosis and treatment technology applications. The company was founded in 2014 and is headquartered in Tainan, Taiwan.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADVB

Advanced Biomed Inc

Upgrade your FINVIZ experience